Nine-Year Follow-up of Patients with Relapsed Follicular Lymphoma after Nonmyeloablative Allogeneic Stem Cell Transplant and Autologous Transplant.
Issa F KhouriDenái R MiltonAlison M GulbisElias J JabbourLoretta NastoupilCelina LedesmaPaolo AnderliniQaiser BashirMay DaherJin S ImSwaminathan P IyerDavid MarinRohtesh S MehtaAmanda L OlsonUday R PopatMuzaffar QazilbashNeeraj SainiFelipe SamaniegoGabriela RondonL Jeffrey MedeirosRichard E ChamplinPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
This study shows that alloSCT is curative and confers superior survival compared with autoSCT in patients with follicular lymphoma.